WCBA
EHC icon

Weaver C. Barksdale & Associates’s Encompass Health EHC Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$21K Sell
538
-4
-0.7% -$152 0.02% 155
2017
Q3 		$20K Buy
542
+25
+5% +$891 0.02% 152
2017
Q2 		$20K Sell
517
-47
-8% -$1.72K 0.02% 156
2017
Q1 		$19K Sell
564
-42
-7% -$1.38K 0.02% 160
2016
Q4 		$20K Buy
+606
New +$19.7K 0.03% 158

Other funds holding EHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Weaver C. Barksdale & Associates's EHC Position: Q4 2017 in Review

Weaver C. Barksdale & Associates reduced its Encompass Health (EHC) stake by 0.74% in Q4 2017, selling an estimated $152 and leaving 538 shares worth $21K. The position accounts for 0.02% of the portfolio, ranked #155.

Weaver C. Barksdale & Associates first reported a position in EHC in Q4 2016 and has held it in 5 quarters since. 300 funds tracked by Wall St. Rank hold EHC as of Q4 2017.

  • Weaver C. Barksdale & Associates held 538 shares of Encompass Health worth $21K as of Q4 2017.
  • Weaver C. Barksdale & Associates sold 4 Encompass Health shares in Q4 2017, an estimated $152.
  • Encompass Health made up 0.02% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #155 holding.
  • Weaver C. Barksdale & Associates first reported a position in Encompass Health in Q4 2016 and has held it in 5 quarters since.
  • 300 funds tracked by Wall St. Rank held Encompass Health as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.